Ausgabe Sonderheft 1/2012
Lipid Apheresis – Last Resort or Selective Therapeutic Option? Proceedings of a Symposium held in Bad Oeynhausen, Germany, October 7 – 8, 2011
Inhalt (10 Artikel)
Open Access
Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R)
Juergen R. Schaefer, Bilgen Kurt, Alexander Sattler, Günter Klaus, Muhidien Soufi
Open Access
Role of lipid apheresis in changing times
Peter Schuff-Werner, Sebastian Fenger, Peter Kohlschein
Open Access
Current view: indications for extracorporeal lipid apheresis treatment
Volker Schettler, C. L. Neumann, M. Hulpke-Wette, G. C. Hagenah, E. G. Schulz, E. Wieland
Open Access
Lipid apheresis techniques: current status in Germany
Peter Grützmacher, Claudius Kleinert
Open Access
HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures
Frank van Buuren, Sven Kreickmann, Dieter Horstkotte, Tanja Kottmann, Klaus Peter Mellwig
Open Access
Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis
Nils Ewald, Hans-Ulrich Kloer
Open Access
Fibrinogen/LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss
Martin Canis, Franz Heigl, Markus Suckfuell
Open Access
Therapeutic apheresis in peripheral and retinal circulatory disorders
Alfonso Ramunni, Paola Brescia, Giuseppina De Fino, Giovanni Piscopo, Loreto Gesualdo
Open Access
Lipid apheresis: oxidative stress, rheology, and vasodilatation
K.-P. Mellwig, E. Pulawski, D. Horstkotte, F. van Buuren